Literature DB >> 12110822

Maternal asthma, infant feeding, and the risk of asthma in childhood.

Wendy H Oddy1, Jennifer K Peat, Nicholas H de Klerk.   

Abstract

Controversy surrounds the issue of whether children with asthmatic mothers should be breast-fed. The aim of this study was to investigate whether maternal asthma status alters the association between asthma and breast-feeding. In a cohort study of 2602 West Australian children enrolled before birth and followed prospectively, we collected data on method of infant feeding, maternal asthma (as reported by parental questionnaire), atopy (as measured by skin prick test), and current asthma (defined as a physician's diagnosis of asthma and wheeze in the last year) at 6 years of age. The risk of childhood asthma increased if exclusive breast-feeding was stopped (other milk was introduced) before 4 months (odds ratio, 1.28; 95% CI, 1.01-1.62; P =.038), and this risk was not altered by atopy or maternal asthma status. After adjusting for covariates, exclusive breast-feeding for less than 4 months was a significant risk factor for current asthma (odds ratio, 1.35; 95% CI, 1.00-1.82; P =.049). There was no formal statistical interaction between breast-feeding and maternal asthma status (P =.970). In this study maternal asthma status did not modify the association between asthma and breast-feeding duration. We recommend that infants with or without a maternal history of asthma be exclusively breast-fed for 4 months and beyond.

Entities:  

Mesh:

Year:  2002        PMID: 12110822     DOI: 10.1067/mai.2002.125296

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  21 in total

1.  Factors associated with exclusive breastfeeding 2 to 4 weeks following discharge from a large, urban, academic medical center striving for baby-friendly designation.

Authors:  Eileen Difrisco; Karen E Goodman; Wendy C Budin; Marge W Lilienthal; Aviva Kleinman; Barbara Holmes
Journal:  J Perinat Educ       Date:  2011

2.  Prevention strategies for asthma--primary prevention.

Authors: 
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

3.  Current studies on two separate topics: breastfeeding postpartum length of hospital stay.

Authors:  Mary Lou Moore
Journal:  J Perinat Educ       Date:  2003

4.  Maternal depressive symptoms, maternal asthma, and asthma in school-aged children.

Authors:  Brock H Medsker; Bronwyn K Brew; Erick Forno; Henrik Olsson; Cecilia Lundholm; Yueh-Ying Han; Edna Acosta-Pérez; Glorisa J Canino; Catarina Almqvist; Juan C Celedón
Journal:  Ann Allergy Asthma Immunol       Date:  2017-01       Impact factor: 6.347

Review 5.  Primary prevention of allergy and asthma is possible.

Authors:  Allan B Becker
Journal:  Clin Rev Allergy Immunol       Date:  2005-02       Impact factor: 8.667

6.  Comparison of biomarkers and parent report of tobacco exposure to predict wheeze.

Authors:  Adam J Spanier; Robert S Kahn; Yingying Xu; Richard Hornung; Bruce P Lanphear
Journal:  J Pediatr       Date:  2011-06-08       Impact factor: 4.406

7.  Evaluating the efficacy of breastfeeding guidelines on long-term outcomes for allergic disease.

Authors:  V Bion; G A Lockett; N Soto-Ramírez; H Zhang; C Venter; W Karmaus; J W Holloway; S H Arshad
Journal:  Allergy       Date:  2016-01-21       Impact factor: 13.146

8.  Prospective Cohort Study of Breastfeeding and the Risk of Childhood Asthma.

Authors:  Anne Kristine Lossius; Maria Christine Magnus; Jon Lunde; Ketil Størdal
Journal:  J Pediatr       Date:  2018-02-01       Impact factor: 4.406

9.  Reliability of reported breastfeeding duration among reproductive-aged women from Mexico.

Authors:  Lea A Cupul-Uicab; Beth C Gladen; Mauricio Hernández-Avila; Matthew P Longnecker
Journal:  Matern Child Nutr       Date:  2009-04       Impact factor: 3.092

10.  The ratio of n-6 to n-3 fatty acids in maternal diet influences the induction of neonatal immunological tolerance to ovalbumin.

Authors:  M Korotkova; E Telemo; Y Yamashiro; L A Hanson; B Strandvik
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.